Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome
Washington University School of Medicine
Washington University School of Medicine
UNC Lineberger Comprehensive Cancer Center
Thomas Jefferson University
Washington University School of Medicine
City of Hope Medical Center
Wake Forest University Health Sciences
Stanford University
Stanford University
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Virginia Commonwealth University
Northwestern University
Northwestern University
Mayo Clinic
Case Comprehensive Cancer Center
Swiss Cancer Institute
City of Hope Medical Center
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Case Comprehensive Cancer Center
City of Hope Medical Center
Indiana University
Ohio State University Comprehensive Cancer Center
Rutgers, The State University of New Jersey
Boston Medical Center
Fox Chase Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
University of Washington
NYU Langone Health
Northwestern University
Northwestern University